Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9R3Z

Exploiting ALDH1A2 and ALDH1A3 Isoform Variability for Crystallization Screening

Summary for 9R3Z
Entry DOI10.2210/pdb9r3z/pdb
DescriptorRetinal dehydrogenase 2 (2 entities in total)
Functional Keywordsaldehyde dehydrogenase, cancer stem cells, retinaldehyde, aldh1a3, structure-based drug discovery;, oxidoreductase
Biological sourceHomo sapiens (human)
Total number of polymer chains4
Total formula weight227134.75
Authors
Garaavglia, S.,Mazzorana, M. (deposition date: 2025-05-06, release date: 2025-09-03)
Primary citationSiragusa, S.,Garavaglia, S.,Mazzorana, M.
Exploiting ALDH1A2 and ALDH1A3 isoform variability for crystallisation screening.
Biochem.Biophys.Res.Commun., 780:152469-152469, 2025
Cited by
PubMed Abstract: Members of the human aldehyde dehydrogenase family 1 (ALDH1As) play a crucial role in converting retinal to retinoic acid, a multifunctional bioactive compound. Most evidence highlight ALDH1As as markers for cancer stem cells correlating with tumour aggressiveness. Increasing structural and biochemical data about these important isoenzymes have been reported in literature. Crystal structures of human ALDH1A2 have been so far only obtained in the presence of ligands/cofactors from vapour diffusion hanging drops. Apo-enzyme structures have been described only for the other two members of the family (ALDH1A1 and ALDH1A3) serving as the basis for their co-crystallisation with various ligands. In this study, we describe the first apo-ALDH1A2 structure obtained from nanolitre sitting-drop crystallisation, which expands the potential for high-throughput structure-based drug discovery studies on this isoform. We also explore the crystallisability of NAD-ALDH1A3 from microlitre drops and compare the structure obtained from it with that of apo-ALDH1A2. Finally, we propose strategies compatible with robotic setups to streamline structural studies on ALDH1A3 and facilitate the exploration of extensive ligand libraries.
PubMed: 40829477
DOI: 10.1016/j.bbrc.2025.152469
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.8 Å)
Structure validation

243531

数据于2025-10-22公开中

PDB statisticsPDBj update infoContact PDBjnumon